A thyroid ultrasound is ordered to get a detailed picture of the thyroid gland’s physical structure, most commonly to evaluate lumps (nodules), determine whether they look suspicious for cancer, and guide decisions about whether a biopsy is needed. It’s a painless, radiation-free imaging test that uses sound waves to reveal things blood tests simply can’t: the size, shape, and internal characteristics of the gland and any growths within it.
What Blood Tests Can’t Tell You
Thyroid blood tests and thyroid ultrasounds answer fundamentally different questions. Blood tests measure hormone levels and antibodies, telling your doctor whether your thyroid is overactive, underactive, or under immune attack. An ultrasound shows the physical structure of the gland: its size, shape, position, and whether it contains nodules. You can have perfectly normal blood work and still harbor nodules that need monitoring, or you can have abnormal hormone levels with a structurally normal-looking gland. That’s why doctors often order both together.
Evaluating Thyroid Nodules
The most common reason for a thyroid ultrasound is to investigate a nodule, whether your doctor felt one during a neck exam or one showed up unexpectedly on another scan like a CT or carotid artery ultrasound. Thyroid nodules are remarkably common. High-resolution ultrasound detects them in roughly 67% of the general population, a rate comparable to what’s found in autopsy studies. The vast majority are tiny (under 10 mm in 70 to 83% of cases) and cause no symptoms.
Only about 5% of nodules are large enough to feel by hand. The rest are “incidentalomas,” discovered by accident during imaging done for an unrelated reason. European clinical guidelines recommend that anyone with a suspected nodule, whether felt on exam or found incidentally, get a full neck ultrasound that includes the thyroid gland and the surrounding lymph node compartments on both sides of the neck.
Distinguishing Suspicious From Harmless Nodules
Not all nodules look alike on ultrasound, and the specific visual features help your doctor estimate cancer risk without surgery. In one study of 144 patients, only about 10% of nodules turned out to be malignant. But the malignant ones shared a recognizable pattern: they were more likely to be solid rather than fluid-filled, darker than surrounding tissue on the ultrasound image (hypoechoic), single rather than clustered, and to have irregular or blurry edges. Calcifications, tiny bright spots within the nodule, also raised suspicion.
Having irregular edges increased the chance of malignancy about 5 times, while certain types of microcalcifications raised it as much as 39 times. Interestingly, nodule size alone was not a reliable way to tell benign from malignant. A large nodule isn’t necessarily more dangerous than a small one; what matters is how it looks internally.
Radiologists use a standardized scoring system called ACR TI-RADS to translate these visual features into a risk category. Each nodule gets points based on its composition, brightness, shape, margins, and internal spots. Higher scores mean higher suspicion. Nodules scored as TI-RADS 4 (moderately suspicious) had a cancer rate of about 11% after surgical removal, while TI-RADS 5 (highly suspicious) nodules had a cancer rate of 71%. Lower-scoring nodules may need no further workup at all.
Guiding Biopsies
When a nodule looks suspicious enough to warrant a biopsy, ultrasound plays a second critical role: it guides the needle in real time. During a fine needle aspiration, the doctor watches the ultrasound screen while inserting a thin needle into the nodule to collect cells for analysis. This approach has largely replaced the older method of guiding the needle by feel alone.
The accuracy difference is significant. Ultrasound-guided biopsies have a sensitivity of about 90%, meaning they correctly identify 90 out of 100 cancerous nodules. Biopsies guided only by touch drop to around 71% sensitivity, missing nearly 30% of cancers. Ultrasound guidance also gives the doctor a preview of the nodule’s characteristics before the needle even goes in, adding another layer of information to the procedure.
Diagnosing Autoimmune Thyroid Conditions
Ultrasound isn’t only about nodules. It can also reveal patterns consistent with autoimmune thyroid diseases like Hashimoto’s thyroiditis and Graves’ disease, sometimes even before symptoms become obvious.
In Hashimoto’s thyroiditis, the most common finding is a diffusely dark (hypoechoic) gland, seen in about 45% of cases. Another frequent pattern is darkening concentrated around the edges of the gland, appearing in roughly 40% of Hashimoto’s patients. Graves’ disease shows its own pattern, often with increased blood flow visible on Doppler ultrasound, a feature that helps distinguish it from Hashimoto’s even though both conditions can make the gland look darker than normal. Moderate to severe darkening on ultrasound can raise suspicion for autoimmune thyroid disease even when there’s no clinical reason to expect it.
Monitoring Known Nodules Over Time
If you’ve already had a nodule biopsied and the result came back benign, your doctor will likely schedule follow-up ultrasounds to watch for changes. The American Thyroid Association recommends a repeat ultrasound 6 to 18 months after the initial benign biopsy. Some guidelines also suggest repeating the biopsy itself during that window, even if the nodule hasn’t grown.
More recent data suggests that for nodules over 1 cm with a benign biopsy, a repeat evaluation at 2 to 4 years may be sufficient. The reasoning: in the small number of cases where a benign biopsy result turns out to be wrong, the cancer is typically slow-growing enough that catching it a few years later still leads to successful treatment. Your follow-up schedule will depend on how suspicious the nodule looked initially and whether it changes in size or appearance over time.
Other Reasons Your Doctor May Order One
Beyond nodules and autoimmune disease, a thyroid ultrasound may be ordered if you have a visibly enlarged thyroid (goiter), a family history of thyroid cancer, prior radiation exposure to the head or neck, or unexplained symptoms like difficulty swallowing or a persistent lump in the throat. It’s also used after thyroid cancer treatment to check for recurrence in the thyroid bed or nearby lymph nodes. Because the test involves no radiation and no needles, it can be repeated as often as needed without any cumulative risk.